New JerseyHealthy Living Quality Measures Compared to Achievable Benchmarks

The NHQDR quality measures specific to Healthy Living are compared to achievable benchmarks, which are derived from the top-performing States. Better performance of a State can mean higher or lower values of a measure, depending on the desired outcome. For example, low values are desirable for measures such as infant mortality, whereas high values are desirable for measures such as preventative screening. The categories of achievement have been standardized across the measure definitions so that:

 
Far away from benchmark - a State's value for a measure has not achieved 50% of the benchmark.
 
Close to benchmark - a State's value for a measure is between 50% and 90% of a benchmark (i.e., worse than the benchmark but has achieved at least half of the benchmark but not as much as 90% of a benchmark).
 
Achieved benchmark or better - a State's value for a measure is no worse than 90% of the benchmark value, the measure has achieved the benchmark. This category also includes the case in which the measure’s value is equal to or better than the benchmark.
Measures That Achieved Benchmark or Better
Measure Estimate Benchmark Distance to Benchmark
Long-stay nursing home residents with moderate to severe pain 2.7 4.7 Achieved: 42% better
Short-stay nursing home residents with moderate to severe pain 6.4 10.8 Achieved: 41% better
Home health care patients whose ability to walk or move around improved 76.4 71.5 Achieved: 7% better
Home health care patients whose pain when moving around decreased 77.9 73.8 Achieved: 6% better
Home health care patients whose ability to get in and out of bed improved 73.9 70.3 Achieved: 5% better
Home health care patients whose shortness of breath decreased 78.9 77.0 Achieved: 2% better
Home health care patients whose bathing improved 76.8 75.4 Achieved: 2% better
Long-stay nursing home residents whose ability to move independently worsened 13.6 13.7 Achieved: 1% better
Long-stay nursing home patients who were assessed and appropriately given the seasonal influenza vaccine 93.6 94.1 0.5%
Adults who received a blood cholesterol measurement in the last 5 years 81.5 82.3 0.9%
Hospital patients who received influenza vaccination 96.0 97.0 1.1%
Short-stay nursing home residents who were assessed for pneumococcal vaccination 94.2 95.3 1.1%
Short-stay nursing home patients who had flu vaccination appropriately given 91.6 92.9 1.4%
Home health patients who had improvement in upper body dressing 76.1 77.4 1.7%
Long-stay nursing home residents who were assessed for pneumococcal vaccination 96.3 98.0 1.7%
Hospital patients who received pneumococcal immunization 95.2 97.2 2.0%
Children ages 19-35 months who received 1 or more doses of varicella vaccine 92.3 95.7 3.6%
Home health care patients who stayed at home after an episode of home health care 74.7 77.5 3.6%
Children ages 19-35 months who received 4 or more doses of diphtheria-tetanus-pertussis vaccine 87.0 90.6 4.0%
Adolescents ages 13-15 who received 1 or more doses of meningococcal conjugate vaccine 91.6 95.4 4.0%
Children ages 19-35 months who received 3 or more doses of polio vaccine 93.3 97.3 4.1%
Children ages 19-35 months who received 1 or more doses of measles-mumps-rubella vaccine 92.4 96.4 4.1%
Adolescents ages 16-17 who received 1 or more doses of meningococcal conjugate vaccine 91.8 96.2 4.5%
Adolescents ages 16-17 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years 91.1 95.9 5.0%
Long-stay nursing home residents with too much weight loss 5.7 5.4 6.1%
Long-stay nursing home residents whose need for help with daily activities increased 11.3 10.6 6.4%
Adolescents ages 13-15 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years 89.1 95.2 6.4%
Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine 89.9 96.4 6.7%
Home health patients who had influenza vaccination during flu season 77.5 84.8 8.6%
Measures That Are Close to Benchmark
Measure Estimate Benchmark Distance to Benchmark
Adults age 65 and over who received an influenza vaccination in the last flu season 60.8 70.3 13.5%
Home health patients who had pneumococcal polysaccharide vaccination 73.6 86.1 14.5%
Adults age 65 and over who ever received pneumococcal vaccination 65.7 78.7 16.5%
Adults ages 18-64 at high risk (e.g., COPD) who ever received pneumococcal vaccination 34.7 44.8 22.6%
Adults ages 18-64 at high risk (e.g., COPD) who received an influenza vaccination in the last flu season 36.7 47.8 23.2%
Breast cancer diagnosed at advanced stage (regional, distant stage, or local stage with tumor greater than 2 cm) per 100,000 women age 40 and over 93.7 72.8 28.7%
Colorectal cancer diagnosed at advanced stage (tumors diagnosed at regional or distant stage) per 100,000 population age 50 and over 67.9 47.2 44.0%
Measures That Are Far From Benchmark
Measure Estimate Benchmark Distance to Benchmark
Cervical cancer diagnosed at advanced stage (all invasive tumors) per 100,000 women age 20 and over 11.4 7.6 50.8%
Low-risk, long-stay nursing home residents with loss of control of bowels or bladder 42.0 16.7 151.5%
Long-stay nursing home residents with physical restraints 0.8 0.2 265.2%
Measures With No Available Benchmark Information or Supplemental Measures
Measure Estimate Benchmark Distance to Benchmark
Composite measure: Adults ages 50-75 who received any type of colorectal cancer screening 65.8
Children ages 19-35 months who received 4 or more doses of pneumococcal conjugate vaccine 80.9
Children ages 19-35 months who received full series Haemophilus influenzae type B 85.6
Composite measure: Children ages 19-35 months who received all recommended vaccines 70.2
Adolescent aged 13-15 years who received 3 or more doses of human papillomavirus (HPV) vaccine 36.6
Adolescents ages 13-15 years (excluding adolescents who have had varicella) vaccinated with at least 2 doses of varicella 88.0
Adolescents ages 16-17 years (excluding adolescents who have had varicella) vaccinated with at least 2 doses of varicella 87.2
Adolescent ages 16-17 years who received 3 or more doses of human papillomavirus (HPV) vaccine 41.4